Abbvie Profit Margin

The latest profit margin for ABBV is 9.82% as of June 2026. That compares with 6.45% in the prior-year period — up 52.1% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Abbvie's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABBV's profit margin moved from 6.45% to 9.82% — a 52.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abbvie's valuation or profitability profile.

Against Healthcare companies, ABBV currently prints 9.82% for profit margin, while the sector average sits near 21.34%. That is roughly 54.0% below the sector mean. Large gaps often invite a closer look at Abbvie's growth, margins, and balance sheet.

Profit Margin shows how effectively Abbvie converts resources into returns. At 9.82%, ABBV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.45% in the prior-year period — up 52.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABBV's profit margin (9.82%), review year-over-year change from 6.45%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.